MarketPeel
Insider Trading Intelligence
Pricing
…
FC

Fred E. Cohen

NTLA
DIRECTOR · INTELLIA THERAPEUTICS, INC. · CIK 0001339358
FILING MIX · LIFETIME86%/14%
BUYS
59
SELLS
10
TOTAL VALUE
$3.98M
COMPANIES
6
ACTIVE SINCE
May 2020
HOLDINGS NOW
436,133
AVG SELL PX
$26.86
TRADE KIND
SHOWING 69 / 69
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Fred E. Cohen, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+33.33%+8.93%+1.28%+7.65%+1.02%—
14d3+100.00%+10.68%+1.89%+8.79%-6.02%—
30d3+100.00%+8.81%+3.69%+5.12%-8.39%—
60d3+33.33%+26.42%+5.62%+20.80%+8.37%—
90d3+33.33%+34.48%+8.64%+25.85%+15.71%—
180d3+33.33%+80.95%+17.71%+63.24%+55.31%—
1y3(1 pending)+0.00%+38.87%+41.88%-3.01%-3.01%—
2y3(1 pending)+100.00%-38.49%+36.75%-75.24%-75.24%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
NTLA · 216,653 shares · as of Jun 9, 2026
054,163108,327162,490216,653202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 59 buys / 10 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
9,795——165,060Jun 12, 2026Jun 16, 2026 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,300——13,300Jun 9, 2026Jun 10, 2026 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
9,200——216,653Jun 9, 2026Jun 10, 2026 ↗View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,582——20,582May 27, 2026May 29, 2026 ↗View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,093——21,727May 27, 2026May 29, 2026 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
150,000$9.35$1.40M207,453Jan 5, 2026Jan 7, 2026 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
12,103——155,265Jun 13, 2025Jun 17, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,450——11,450Jun 11, 2025Jun 13, 2025 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,000——57,453Jun 11, 2025Jun 13, 2025 ↗View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,634——16,634May 29, 2025Jun 2, 2025 ↗View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
65,351——65,351May 29, 2025Jun 2, 2025 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,000——10,000Aug 6, 2024Aug 7, 2024 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
16,048——16,048Jun 14, 2024Jun 18, 2024 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
16,048——16,048Jun 14, 2024Jun 20, 2024 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
10,570——143,162Jun 14, 2024Jun 18, 2024 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
11,515——11,515Jun 12, 2024Jun 14, 2024 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,737——49,453Jun 12, 2024Jun 14, 2024 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
25,070——25,070May 23, 2024May 28, 2024 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
6,176——22,693May 23, 2024May 28, 2024 ↗View →
KYTX
KYVERNA THERAPEUTICS, INC.
PURCHASE
4,523,924——4,523,924Feb 12, 2024Feb 14, 2024 ↗View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
7,356,162——0Feb 12, 2024Feb 14, 2024 ↗View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
4,401,771——0Feb 12, 2024Feb 14, 2024 ↗View →
KYTX
KYVERNA THERAPEUTICS, INC.
SALE
8,830,901——0Feb 12, 2024Feb 14, 2024 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,000——10,000Sep 7, 2023Sep 8, 2023 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
69,339$9.54$661.5K69,339Jul 26, 2023Jul 28, 2023 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
18,844——132,592Jun 16, 2023Jun 21, 2023 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
29,136——29,136Jun 16, 2023Jun 21, 2023 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,425——41,716Jun 14, 2023Jun 16, 2023 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,473——6,473Jun 14, 2023Jun 16, 2023 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
18,350——18,350May 24, 2023May 26, 2023 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
4,385——16,517May 24, 2023May 26, 2023 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
1,062——113,748Jan 6, 2023Jan 9, 2023 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
3,480——12,132Oct 24, 2022Oct 26, 2022 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
1,460——1,460Oct 24, 2022Oct 26, 2022 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
15,660——15,660Oct 24, 2022Oct 26, 2022 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
803——112,686Oct 4, 2022Oct 4, 2022 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
4,863——111,883Jun 16, 2022Jun 21, 2022 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
7,606——7,606Jun 16, 2022Jun 21, 2022 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
5,197——37,291Jun 14, 2022Jun 16, 2022 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,688——7,688Jun 14, 2022Jun 16, 2022 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 8, 2022Jun 10, 2022 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
2,652——8,652Oct 24, 2021Oct 26, 2021 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
15,831——15,831Oct 24, 2021Oct 26, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
3,382——3,382Jun 23, 2021Jun 25, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
2,094——2,094Jun 23, 2021Jun 25, 2021 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
1,812——1,812Jun 16, 2021Jun 21, 2021 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
1,127——107,020Jun 16, 2021Jun 21, 2021 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 7, 2021Jun 8, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
SALE
20,000——18,000Jan 20, 2021Jan 22, 2021 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASE
20,000$13.78$275.6K30,000Jan 20, 2021Jan 22, 2021 ↗View →
CDNA
CAREDX, INC.
PURCHASE
15,000$14.74$221.1K105,893Jan 6, 2021Jan 6, 2021 ↗View →
CDNA
CAREDX, INC.
SALE
15,000——0Jan 6, 2021Jan 6, 2021 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
27,000——27,000Oct 24, 2020Oct 27, 2020 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
6,000——6,000Oct 24, 2020Oct 27, 2020 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
894$27.95$25.0K894Oct 24, 2020Oct 27, 2020 ↗View →
PGNY
PROGYNY, INC.
PURCHASEGRANT
Stock grant
1,845——1,845Oct 24, 2020Nov 20, 2020 ↗View →
VCYT
VERACYTE, INC.
PURCHASE
10,000$7.60$76.0K10,000Oct 19, 2020Oct 20, 2020 ↗View →
VCYT
VERACYTE, INC.
SALE
10,000——0Oct 19, 2020Oct 20, 2020 ↗View →
CDNA
CAREDX, INC.
SALE
9,745——0Sep 21, 2020Sep 22, 2020 ↗View →
CDNA
CAREDX, INC.
PURCHASE
9,745$4.95$48.2K90,893Sep 21, 2020Sep 22, 2020 ↗View →
CDNA
CAREDX, INC.
SALE
6,679——0Sep 21, 2020Sep 22, 2020 ↗View →
CDNA
CAREDX, INC.
PURCHASE
6,679$5.49$36.7K81,148Sep 21, 2020Sep 22, 2020 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
3,190——74,469Jun 18, 2020Jun 19, 2020 ↗View →
CDNA
CAREDX, INC.
PURCHASEGRANT
Stock grant
4,978$31.35$156.1K4,978Jun 18, 2020Jun 19, 2020 ↗View →
NTLA
INTELLIA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
19,000——19,000Jun 18, 2020Jun 19, 2020 ↗View →
URGN
UROGEN PHARMA LTD.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 8, 2020Jun 8, 2020 ↗View →
VCYT
VERACYTE, INC.
PURCHASEGRANT
Stock grant
10,000——10,000Jun 8, 2020Jun 9, 2020 ↗View →
VCYT
VERACYTE, INC.
SALE
4,153$27.51$114.2K0May 18, 2020May 19, 2020 ↗View →
VCYT
VERACYTE, INC.
SALE
35,847$26.79$960.3K4,153May 18, 2020May 19, 2020 ↗View →
Other insiders · NTLA
Loading peer insiders…
About this filer
CIK 0001339358
ROLE
Director
PRIMARY
NTLA
COMPANIES
6
ACTIVE SINCE
May 2020
MARKETPEEL · /INSIDER/0001339358DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback